WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapies

This article has been withdrawn at the request of the authors and editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/policies/article-withdrawal.

Detalles Bibliográficos
Autores principales: Etemadifar, M., Aghababaee, A., Sedaghat, N., Rayani, M., Nouri, H., Abhari, A., Salari, M., Majdinasab, N., Ghiasian, M., Bayati, A., Nabavi, S.M., Mansouri, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492065/
https://www.ncbi.nlm.nih.gov/pubmed/33039152
http://dx.doi.org/10.1016/j.neurol.2020.08.001
_version_ 1783582312758247424
author Etemadifar, M.
Aghababaee, A.
Sedaghat, N.
Rayani, M.
Nouri, H.
Abhari, A.
Salari, M.
Majdinasab, N.
Ghiasian, M.
Bayati, A.
Nabavi, S.M.
Mansouri, A.
author_facet Etemadifar, M.
Aghababaee, A.
Sedaghat, N.
Rayani, M.
Nouri, H.
Abhari, A.
Salari, M.
Majdinasab, N.
Ghiasian, M.
Bayati, A.
Nabavi, S.M.
Mansouri, A.
author_sort Etemadifar, M.
collection PubMed
description This article has been withdrawn at the request of the authors and editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/policies/article-withdrawal.
format Online
Article
Text
id pubmed-7492065
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-74920652020-09-16 WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapies Etemadifar, M. Aghababaee, A. Sedaghat, N. Rayani, M. Nouri, H. Abhari, A. Salari, M. Majdinasab, N. Ghiasian, M. Bayati, A. Nabavi, S.M. Mansouri, A. Rev Neurol (Paris) Article This article has been withdrawn at the request of the authors and editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/policies/article-withdrawal. Elsevier Masson SAS. 2020-09-15 /pmc/articles/PMC7492065/ /pubmed/33039152 http://dx.doi.org/10.1016/j.neurol.2020.08.001 Text en © 2020 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Etemadifar, M.
Aghababaee, A.
Sedaghat, N.
Rayani, M.
Nouri, H.
Abhari, A.
Salari, M.
Majdinasab, N.
Ghiasian, M.
Bayati, A.
Nabavi, S.M.
Mansouri, A.
WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapies
title WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapies
title_full WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapies
title_fullStr WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapies
title_full_unstemmed WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapies
title_short WITHDRAWN: Incidence and mortality of COVID-19 in Iranian multiple sclerosis patients treated with disease-modifying therapies
title_sort withdrawn: incidence and mortality of covid-19 in iranian multiple sclerosis patients treated with disease-modifying therapies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492065/
https://www.ncbi.nlm.nih.gov/pubmed/33039152
http://dx.doi.org/10.1016/j.neurol.2020.08.001
work_keys_str_mv AT etemadifarm withdrawnincidenceandmortalityofcovid19iniranianmultiplesclerosispatientstreatedwithdiseasemodifyingtherapies
AT aghababaeea withdrawnincidenceandmortalityofcovid19iniranianmultiplesclerosispatientstreatedwithdiseasemodifyingtherapies
AT sedaghatn withdrawnincidenceandmortalityofcovid19iniranianmultiplesclerosispatientstreatedwithdiseasemodifyingtherapies
AT rayanim withdrawnincidenceandmortalityofcovid19iniranianmultiplesclerosispatientstreatedwithdiseasemodifyingtherapies
AT nourih withdrawnincidenceandmortalityofcovid19iniranianmultiplesclerosispatientstreatedwithdiseasemodifyingtherapies
AT abharia withdrawnincidenceandmortalityofcovid19iniranianmultiplesclerosispatientstreatedwithdiseasemodifyingtherapies
AT salarim withdrawnincidenceandmortalityofcovid19iniranianmultiplesclerosispatientstreatedwithdiseasemodifyingtherapies
AT majdinasabn withdrawnincidenceandmortalityofcovid19iniranianmultiplesclerosispatientstreatedwithdiseasemodifyingtherapies
AT ghiasianm withdrawnincidenceandmortalityofcovid19iniranianmultiplesclerosispatientstreatedwithdiseasemodifyingtherapies
AT bayatia withdrawnincidenceandmortalityofcovid19iniranianmultiplesclerosispatientstreatedwithdiseasemodifyingtherapies
AT nabavism withdrawnincidenceandmortalityofcovid19iniranianmultiplesclerosispatientstreatedwithdiseasemodifyingtherapies
AT mansouria withdrawnincidenceandmortalityofcovid19iniranianmultiplesclerosispatientstreatedwithdiseasemodifyingtherapies

Ejemplares similares